Latest Diabetes Stories
Adding more vegetables to meals is one of the simplest things that can be done to drastically improve health. Flax Seasoning discusses how eating more vegetables can improve health and provides some simple ways to add more vegetables to each meal. Arlington, VA (PRWEB) May 20, 2013 Adding more vegetables to meals is one of the simplest things that can be done to drastically improve health. Vegetables have been shown to help decrease chances of acquiring heart disease, diabetes, and...
Actos (pioglitazone) is a Type 2 diabetes drugs that was approved by the U.S. Food and Drug Administration (FDA) in 1999. Parker Waichman LLP has filed a lawsuit on behalf of a South Dakota man who took the drug, and alleges that it caused his bladder cancer; the case is one of thousands filed into the Actos multidistrict litigation, where Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee. New York, NY (PRWEB) May 20, 2013 Parker...
HOLLYWOOD, Fla., May 20, 2013 /PRNewswire-USNewswire/ -- After successfully leading the Diabetes Research Institute Foundation (DRIF) for two decades, Robert A. Pearlman, 67, of Boca Raton, FL, announced that he will be stepping down from his position as president and CEO effective June 30, 2013. (Photo: http://photos.prnewswire.com/prnh/20130520/DC17414) (Logo: http://photos.prnewswire.com/prnh/20120405/DC83112LOGO) Mr. Pearlman was recruited to the DRI Foundation in 1993, after...
Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in Philadelphia. "Sleep apnea, a condition associated with breathing disturbances during sleep is known to be associated with abnormalities in glucose metabolism, but whether treatment of sleep apnea has any beneficial effects on glucose metabolism is still under...
Continues to accept Medicare insurance for diabetes testing supplies WOONSOCKET, R.I., May 20, 2013 /PRNewswire/ -- CVS/pharmacy is reminding patients with diabetes that one of the most important ways they can manage their disease is to perform regular testing of their blood sugar (glucose) levels. While the number of providers that will accept Medicare coverage for diabetes testing supplies is expected to decline after July 1, 2013 due to Medicare changes, CVS/pharmacy is...
AbbVie presents results of Phase 2b studies NORTH CHICAGO, Ill., May 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease (CKD) and type 2 diabetes. SONAR is a large, multinational,...
BiologicTx Sequence(TM) Enables Transplant Clinicians to Better Understand the Therapeutic Impact of Progressive and Routine Protocols while Ensuring Compliance TOTOWA, N.J., May 20, 2013 /PRNewswire/ -- BiologicTx(®) [www.biologictx.com], the first solely focused infusion and pharmacy provider of biologic and oral transplant therapy management, today announced the unveiling of their new proprietary transplant therapeutic data management and analytics program, BiologicTx...
BOSTON, May 20, 2013 /PRNewswire/ -- Rhythm announced today the results of a second Phase 1b clinical trial of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis in type 1 diabetic patients. The trial demonstrated that RM-131 significantly accelerates early gastric emptying and reduces upper gastrointestinal (GI) symptoms in type 1 diabetic patients with diabetic gastroparesis. The findings were presented at the Digestive Disease Week 2013...
-- Despite high prevalence of symptoms, rate of gastroparesis diagnosis is low among those with type 2 diabetes -- BOSTON, May 20, 2013 /PRNewswire/ -- Rhythm announced today the presentation of results from a new epidemiology study demonstrating a higher prevalence of gastroparesis symptoms among diabetic patients in the U.S. than previously recognized. Prevalence of these symptoms is high among patients with both type 1 and type 2 diabetes, but this condition is significantly...
SAN DIEGO, May 20, 2013 /PRNewswire/ -- Enrollment of patients with Type 2 diabetes is underway in Elcelyx Therapeutics' Phase 2b dose-finding clinical trial of product candidate NewMet(TM), a delayed-release formulation of generic metformin, the foundational treatment for Type 2 diabetes. Elcelyx expects to complete enrollment of 240 patients in the multicenter U.S. program in June. Results of the trial's primary endpoint of change in fasting plasma glucose are expected in late...
Latest Diabetes Reference Libraries
Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...
Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...
